Most retinoblastoma survivors have normal psychosocial functioning

the ONA take:

Most retinoblastoma survivors do not have poorer psychosocial functioning compared with people without cancer, a recent study published online ahead of print in the Journal of Clinical Oncology has shown.

Although survival rates for patients with retinoblastoma are higher than 95% in the United States, there is limited data about the long-term psychosocial outcomes of these survivors.

For the study, researchers surveyed 470 retinoblastoma survivors diagnosed between 1932 and 1994 and treated in New York. Of those, 53.6% had retinoblastoma in both eyes.

Participants completed a comprehensive questionnaire by mail or telephone to evaluate psychosocial outcomes such as psychological distress, anxiety, depression, fear of cancer recurrence, satisfaction with facial appearance, and post-traumatic stress symptoms.

Results showed that retinoblastoma survivors did not have significantly higher rates of depression, somatization, distress, or anxiety compared with noncancer controls.

Researchers also found that bilateral and unilateral retinoblastoma survivors have similar psychological symptoms.

According to the American Cancer Society, retinoblastoma is a rare disease diagnosed in only approximately 200 to 300 children each year in the United States.

Most retinoblastoma survivors have normal psychosocial functioning
Most retinoblastoma survivors do not have poorer psychosocial functioning compared with people without cancer.
READ FULL ARTICLE From Ascopubs
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs